Concepedia

Satish Vadlakonda

SV

Statistics

Publications

1

Citations

31

H-Index

1

Active since

2021

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

Satish Vadlakonda is an author at BioCryst Pharmaceuticals (United States) specializing in hereditary angioedema, drug design, and prophylactic treatment.

Publications per year

2021–2021

1

Publications

1

Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)

Pravin L. Kotian, Minwan Wu, Satish Vadlakonda et al. · Journal of Medicinal Chemistry · 2021 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

1–1 of 1